Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influvac immune response study in MGUS
NL-OMON34204Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine in influenza (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: Humoral immune response by haemagglutination inhibition, Influenza-specific B-cell response by ELISpot and 5 more. Started Oct 2010; status: active, not recruiting.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NL-OMON34204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34204.